MACROGENICS
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.
MACROGENICS
Industry:
Biotechnology Health Care Manufacturing
Founded:
2000-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.macrogenics.com
Total Employee:
501+
Status:
Active
Contact:
3012515321
Email Addresses:
[email protected]
Total Funding:
165.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-07-17 | Raven Biotechnologies | Raven Biotechnologies acquired by MacroGenics | N/A |
| 2002-06-07 | Eliance Biotechnology | Eliance Biotechnology acquired by MacroGenics | N/A |
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - MacroGenics
Nextech Venture
Nextech Venture investment in Series D - MacroGenics
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series D - MacroGenics
Mitsubishi UFJ
Mitsubishi UFJ investment in Series D - MacroGenics
Arcus Ventures
Arcus Ventures investment in Series D - MacroGenics
TPG
TPG investment in Series D - MacroGenics
Innovis Investments
Innovis Investments investment in Series D - MacroGenics
Alta Partners
Alta Partners investment in Series D - MacroGenics
Ventures West
Ventures West investment in Series D - MacroGenics
CIDC Consultants
CIDC Consultants investment in Series D - MacroGenics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-28 | MacroGenics Announces Executive Promotion |
Official Site Inspections
http://www.macrogenics.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.15 K
- Host name: 77.113.185.35.bc.googleusercontent.com
- IP address: 35.185.113.77
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "MacroGenics"
MacroGenics – Developing innovative antibody-based cancer …
We are a biopharmaceutical company focused on developing and commercializing innovative …See details»
About Us - MacroGenics
MacroGenics is a biopharmaceutical company focused on discovering, developing, …See details»
Company Overview - MacroGenics
As a biopharmaceutical company, our team of 240+ dedicated individuals is focused on …See details»
Investors | MacroGenics, Inc.
Nov 5, 2024 · MacroGenics is a biopharmaceutical company focused on developing, …See details»
MacroGenics, Inc. - LinkedIn
MacroGenics is a leader in the discovery and development of innovative medicines that utilize …See details»
MacroGenics - Crunchbase Company Profile & Funding
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. Analysts have valued MacroGenics, Inc. (NASDAQ:MGNX) at US$15.10 after its latest results.See details»
MacroGenics - The Org
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious …See details»
Macrogenics Company Profile 2024: Stock Performance …
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with …See details»
Scott Koenig, M.D., Ph.D. - MacroGenics, Inc.
Dr. Koenig has been our President, Chief Executive Officer and a director since September …See details»
Our Living Values - MacroGenics
The following list of our living values reflects what is most important to us as an organization …See details»
MacroGenics Company Profile - Office Locations, Competitors
Oct 29, 2024 · MacroGenics, Inc. is a biopharmaceutical company focused on discovering and …See details»
MacroGenics - Contacts, Employees, Board Members, Advisors
MacroGenics is a biotechnology company developing immunotherapeutics to prevent …See details»
MacroGenics, Inc. Information - RocketReach
MacroGenics, Inc. is a Biotechnology Research, Pharmaceuticals, and Biotechnology company …See details»
MacroGenics - Nature Biotechnology
One of MacroGenics' cofounders, Jeffrey Ravetch of the Rockefeller University (New York), …See details»
MacroGenics Announces Leadership Transition - GlobeNewswire
Oct 30, 2024 · MacroGenics is a biopharmaceutical company focused on discovering, …See details»
Careers - MacroGenics
MacroGenics is focused on developing novel medicines to treat life-threatening diseases. We …See details»
MacroGenics, Inc. (MGNX) Stock Price, News, Quote & History
MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and …See details»
MacroGenics - VentureRadar
Website: http://www.macrogenics.com Develops monoclonal antibody-based therapeutics for …See details»
MacroGenics Announces Leadership Transition
MacroGenics is a biopharmaceutical company focused on discovering, developing, …See details»
MGNX Stock Price Quote - Morningstar
6 days ago · Macrogenics Inc is a biotechnology company focused on discovering and …See details»